Radiation-Induced Leiomyosarcoma: Does Antimetabolite Chemotherapy Contribute? A Report of Three Cases

Por Brockstein, Bruce, Mundt, Arno, Haraf, Daniel J., Ferguson, Mark, Montag, Anthony
Publicado em 2003

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy

Por Maggiore, Ronald J., Curran, Emily K., Witt, Mary Ellyn, Haraf, Daniel J., Vokes, Everett E., Cohen, Ezra E.W.
Publicado no J Geriatr Oncol (2013)

SITE OF DISEASE AND TREATMENT PROTOCOL AS CORRELATES OF SWALLOWING FUNCTION IN PATIENTS WITH HEAD AND NECK CANCER TREATED WITH CHEMORADIATION

Por Logemann, Jeri A., Rademaker, Alfred W., Pauloski, Barbara Roa, Lazarus, Cathy L., Mittal, Bharat B., Brockstein, Bruce, MacCracken, Ellen, Haraf, Daniel J., Vokes, Everett E., Newman, Lisa A., Liu, Dachao
Publicado em 2006

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

Por Pederson, Aaron W, Salama, Joseph K, Haraf, Daniel J, Witt, Mary Ellen, Stenson, Kerstin M, Portugal, Louis, Seiwert, Tanguy, Villaflor, Victoria M, Cohen, Ezra EW, Vokes, Everett E, Blair, Elizabeth A
Publicado em 2011

Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

Por Choong, Nicholas W., Vokes, Everett E., Haraf, Daniel J., Tothy, Peter K., Ferguson, Mark K., Kasza, Kristen, Rudin, Charles M., Hoffman, Philip C., Krauss, Stuart A., Szeto, Livia, Mauer, Ann M.
Publicado em 2008

High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial

Por Cohen, Ezra E.W., Haraf, Daniel J., List, Marcy A., Kocherginsky, Masha, Mittal, Bharat B., Rosen, Fred, Brockstein, Bruce, Williams, Rosalyn, Witt, Mary Ellyn, Stenson, Kerstin M., Kies, Merrill S., Vokes, Everett E.
Publicado no J Clin Oncol (2006)

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Por Choong, Nicholas W., Mauer, Ann M., Haraf, Daniel J., Lester, Eric, Hoffman, Philip C., Kozloff, Mark, Lin, Shang, Dancey, Janet E., Szeto, Livia, Grushko, Tatyana, Olopade, Olufunmilayo I., Salgia, Ravi, Vokes, Everett E.
Publicado no J Thorac Oncol (2008)

Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Por Cohen, Ezra E.W., Haraf, Daniel J., Kunnavakkam, Rangesh, Stenson, Kerstin M., Blair, Elizabeth A., Brockstein, Bruce, Lester, Eric P., Salama, Joseph K., Dekker, Allison, Williams, Rosalyn, Witt, Mary Ellyn, Grushko, Tatyana A., Dignam, James J., Lingen, Mark W., Olopade, Olufunmilayo I., Vokes, Everett E.
Publicado em 2010

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

Por Cohen, Ezra E.W., Karrison, Theodore G., Kocherginsky, Masha, Mueller, Jeffrey, Egan, Robyn, Huang, Chao H., Brockstein, Bruce E., Agulnik, Mark B., Mittal, Bharat B., Yunus, Furhan, Samant, Sandeep, Raez, Luis E., Mehra, Ranee, Kumar, Priya, Ondrey, Frank, Marchand, Patrice, Braegas, Bettina, Seiwert, Tanguy Y., Villaflor, Victoria M., Haraf, Daniel J., Vokes, Everett E.
Publicado no J Clin Oncol (2014)